Literature DB >> 8786320

Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES.

K G Lim1, H C Wan, P T Bozza, M B Resnick, D T Wong, W W Cruikshank, H Kornfeld, D M Center, P F Weller.   

Abstract

Eosinophils and CD4+ lymphocytes are preferentially recruited into sites of allergic inflammation. A role for eosinophils in the recruitment of CD4+ lymphocytes has not been defined. We studied the capacity of human eosinophils to release chemoattractants for T lymphocytes. Supernatants of cultured eosinophils contained chemoattractant activity for lymphocytes, which was predominantly due to IL-16 (lymphocyte chemoattractant factor) and RANTES. With neutralizing Abs, eosinophil-derived lymphocyte chemotactic activity was diminished by a mean (+/- SEM) of 60 +/- 3% with polygonal anti-IL-16 Ab, 69 +/- 4% with anti-IL-16 mAb, 48 +/- 3% with anti-CD4 F(ab) (IL-16 receptor blockade), 40 +/- 4% with anti-RANTES mAb, and 88 +/- 5% with a combination of anti-IL-16 and anti-RANTES mAbs. IL-16 and RANTES were detectable in eosinophil-derived supernatants by ELISA. Eosinophils constitutively expressed mRNA transcripts for both IL-16 and RANTES detectable by reverse transcription-PCR and contained preformed IL-16 and RANTES demonstrable by ELISA of cell lysates and by immunocytochemistry of freshly isolated eosinophils. Thus, eosinophils are a source of two cytokines, IL-16 and RANTES, that are chemoattractants for lymphocytes as well as eosinophils. These data indicate that eosinophils could contribute cytokines to enhance the recruitment of additional populations of CD4+ lymphocytes and eosinophils.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786320

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Mechanisms of eosinophil cytokine release.

Authors:  Christianne Bandeira-Melo; Peter F Weller
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-06-14       Impact factor: 2.743

3.  Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes.

Authors:  N L Mathy; W Scheuer; M Lanzendörfer; K Honold; D Ambrosius; S Norley; R Kurth
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

4.  Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus.

Authors:  B Olszewska-Pazdrak; A Casola; T Saito; R Alam; S E Crowe; F Mei; P L Ogra; R P Garofalo
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Cytokine Diversity in Human Peripheral Blood Eosinophils: Profound Variability of IL-16.

Authors:  Michelle Ma; Caroline M Percopo; Daniel E Sturdevant; Albert C Sek; Hirsh D Komarow; Helene F Rosenberg
Journal:  J Immunol       Date:  2019-06-10       Impact factor: 5.422

6.  Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils.

Authors:  Rossana C N Melo; Sandra A C Perez; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  Traffic       Date:  2005-10       Impact factor: 6.215

7.  Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells.

Authors:  A J Puren; G Fantuzzi; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  Replenishment of RANTES mRNA expression in activated eosinophils from atopic asthmatics.

Authors:  J R Velazquez; P Lacy; R Moqbel
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

9.  Interleukin-16 expression and release in bullous pemphigoid.

Authors:  A Frezzolini; G Cianchini; M Ruffelli; S Cadoni; P Puddu; O De Pità
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 10.  Eosinophils in the pathogenesis of allergic airways disease.

Authors:  S G Trivedi; C M Lloyd
Journal:  Cell Mol Life Sci       Date:  2007-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.